SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : wla(warner lambert) -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (784)5/26/1999 9:08:00 PM
From: Bull-like  Respond to of 942
 
Anthony-

There is no question in my mind that the recent correction of Big-Pharmas scared a lot of investors. Another factor that caused this sell-off is the rising margin debt in the market and the severe downfall of internet issues. Many investors have to sell something to meet the margin calls. Give us couple of months (maybe 6?), the big-pharmas will be the darlings of the street again. Right now? Just turn off your screen and come back revisit your pharma portfolios in about an year. We will be fine.

da bull



To: Anthony Wong who wrote (784)5/26/1999 11:52:00 PM
From: Captain Jack  Respond to of 942
 
Tony---WLA has been very consistant tecently ayway....todays mkt performance was outstanding,,, too bad WLA bucked it. WLA has fallen when the mkt drops and falls when the mkt rises-- a no support free fall... when it turns positive maybe it will remain consistant also..



To: Anthony Wong who wrote (784)5/27/1999 2:32:00 AM
From: billkirn  Read Replies (1) | Respond to of 942
 
Anthony: Agouron also brings a cure for the common cold, and brings Remmune, Immune Response Corp. (IMNR). A recent news release indicated that WLA really expects Remmune to be very successful. I hope so. I just invested in IMNR after it dropped 40-50%.
If all goes well, the cure for the common cold should be available in the next 3 years. (my guess)

Your analysis was very informative, Thanks. Bill